Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Return on Equity (2016 - 2026)

Champions Oncology (CSBR) has 15 years of Return on Equity data on record, last reported at 0.63% in Q4 2025.

  • For Q4 2025, Return on Equity rose 406.0% year-over-year to 0.63%; the TTM value through Oct 2025 reached 0.63%, up 406.0%, while the annual FY2025 figure was 5.03%, 1036.0% up from the prior year.
  • Return on Equity reached 0.63% in Q4 2025 per CSBR's latest filing, down from 0.8% in the prior quarter.
  • Across five years, Return on Equity topped out at 9.9% in Q1 2024 and bottomed at 9.66% in Q4 2023.
  • Average Return on Equity over 5 years is 0.23%, with a median of 0.06% recorded in 2022.
  • Peak YoY movement for Return on Equity: crashed -967bps in 2023, then soared 1029bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.08% in 2021, then crashed by -85bps to 0.01% in 2022, then plummeted by -81262bps to 9.66% in 2023, then soared by 65bps to 3.43% in 2024, then soared by 118bps to 0.63% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.63% in Q4 2025, 0.8% in Q3 2025, and 1.02% in Q2 2025.